With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.

Read More Deaths (Fatalities), Paxlovid (Drug), Elderly, Drugs (Pharmaceuticals), Research, National Institutes of Health, Pfizer Inc, United States, your-feed-healthcare